These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27935854)

  • 1. Second-trimester maternal serum markers in the prediction of preeclampsia.
    Luo Q; Han X
    J Perinat Med; 2017 Oct; 45(7):809-816. PubMed ID: 27935854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early second trimester maternal serum markers in the prediction of gestational diabetes mellitus.
    Zhao B; Han X; Meng Q; Luo Q
    J Diabetes Investig; 2018 Jul; 9(4):967-974. PubMed ID: 29288571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
    Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre-eclampsia.
    Spencer K; Cowans NJ; Chefetz I; Tal J; Kuhnreich I; Meiri H
    Prenat Diagn; 2007 Mar; 27(3):258-63. PubMed ID: 17278173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
    Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of small-for-gestational-age neonates: screening by maternal serum biochemical markers at 19-24 weeks.
    Lesmes C; Gallo DM; Gonzalez R; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Sep; 46(3):341-9. PubMed ID: 25969963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia.
    Spencer K; Cowans NJ; Chefetz I; Tal J; Meiri H
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):128-34. PubMed ID: 17149788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum soluble fms-like tyrosine kinase-1 at 22 and 32 weeks in the prediction of pre-eclampsia.
    Wright D; Krajewska K; Bogdanova A; Wright A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):755-61. PubMed ID: 26726123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
    Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
    Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of pre-eclampsia combining NGAL and other biochemical markers with Doppler in the first and/or second trimester of pregnancy. A pilot study.
    Karampas GA; Eleftheriades MI; Panoulis KC; Rizou MD; Haliassos AD; Metallinou DK; Mastorakos GP; Rizos DA
    Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():153-7. PubMed ID: 27599094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of plasma-soluble fms-like tyrosine kinase 1 and uterine artery Doppler for the prediction of preeclampsia in cases of elderly gravida.
    Kulmala L; Phupong V
    Hypertens Res; 2014 Jun; 37(6):538-42. PubMed ID: 24621465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation.
    Tsiakkas A; Saiid Y; Wright A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jul; 215(1):87.e1-87.e17. PubMed ID: 26875953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-trimester maternal serum PP13 in the risk assessment for preeclampsia.
    Romero R; Kusanovic JP; Than NG; Erez O; Gotsch F; Espinoza J; Edwin S; Chefetz I; Gomez R; Nien JK; Sammar M; Pineles B; Hassan SS; Meiri H; Tal Y; Kuhnreich I; Papp Z; Cuckle HS
    Am J Obstet Gynecol; 2008 Aug; 199(2):122.e1-122.e11. PubMed ID: 18539259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester].
    Ye YH; Liu L; Zhan Y; Peng W
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):433-5. PubMed ID: 17083803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First trimester screening of maternal placental protein 13 for predicting preeclampsia and small for gestational age: in-house study and systematic review.
    Schneuer FJ; Nassar N; Khambalia AZ; Tasevski V; Guilbert C; Ashton AW; Morris JM; Roberts CL
    Placenta; 2012 Sep; 33(9):735-40. PubMed ID: 22748852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?
    Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
    Arch Gynecol Obstet; 2013 May; 287(5):865-73. PubMed ID: 23224699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies.
    Bersinger NA; Ødegård RA
    Acta Obstet Gynecol Scand; 2004 Jan; 83(1):37-45. PubMed ID: 14678084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
    J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal determination of serum placental protein 13 during development of preeclampsia.
    Huppertz B; Sammar M; Chefetz I; Neumaier-Wagner P; Bartz C; Meiri H
    Fetal Diagn Ther; 2008; 24(3):230-6. PubMed ID: 18753763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.